Direxion Daily S&P Biotech Bear 3X Shares (LABD)

[THREE-DAY-TRADER]

Sure has been holding up well ever since late September.
Was a nice entry in 15-16 (for a quick flip at the very least in any event).
I've been a little distracted from LABD, focusing on individual stocks.
My view has been, however, that since September it has been a risky & precarious venture trying to short the stock market with any 3x fund (being increasingly hard to predict or time a bottom area).

At this point I would watch to see if the 50 day avg holds on the XBI, which it is now nearing around 63-64. That's a strong clue about any possible change in trend.